Fundación Huésped
Clinical trials sponsored by Fundación Huésped, explained in plain language.
-
Could a simpler HIV pill protect moms and babies?
Disease control Not yet recruitingThis study will test a two-drug HIV pill (Dolutegravir/Lamivudine) in 210 pregnant women who have never taken HIV medication. The goal is to see if it controls the virus and prevents passing HIV to their babies. Participants will be compared to those on standard three-drug therap…
Phase: PHASE4 • Sponsor: Fundación Huésped • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New HIV combo pill tested for rapid start in 100 patients
Disease control Not yet recruitingThis study tests whether a once-daily pill containing doravirine, lamivudine, and tenofovir can quickly control HIV in people who have never taken HIV drugs before. One hundred newly diagnosed adults will take the pill for 48 weeks. The main goal is to see how many have undetecta…
Phase: PHASE4 • Sponsor: Fundación Huésped • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC